Table 2. Postoperative follow-up and outcomes in patients with craniopharyngioma.
Postoperative findings - follow-up | |
Follow-up duration (years) |
4.5±3.9 [0.08; 20] |
Age at last follow-up (years) |
13.7±4.9 [2.9; 29] |
Height SDS |
-1.1±1.6 [-6.4; 2.6] |
BMI SDS |
1.4±1.4 [-2.35; 5.08] |
Relapse (n) |
58 (38.2%) |
Remission (n) |
92 (60.5%) |
Type of surgery |
|
GTR (n) |
97 (63.8%) |
Subtotal (n) |
54 (35.5%) |
Transnasal (n) |
76 (50%) |
Endoscopic (n) |
73 (48%) |
Gamma knife (n) |
2 (1.3%) |
Radiotherapy (n) |
18 (11.8%) |
Postoperative hormone deficiencies in patients | |
Growth hormone deficiency |
99 (65.1%) |
Gonadotropin deficiency (total 109 pubertal status) |
66 (43.4%) |
TSH deficiency |
140 (92.1%) |
ACTH deficiency |
123 (81%) |
Central diabetes insipidus |
120 (78.9%) |
BMI SDS: body mass index standard deviation (SD) score, ACTH: adrenocorticotropic hormone deficiency, TSH: thyroid-stimulating hormone, GTR: gross total resection